3,6,9,12,15-Octadecapentaenoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3,6,9,12,15-Octadecapentaenoic acid
• 英文别名: (3E,6E,9E,12E,15E)-octadeca-3,6,9,12,15-pentaenoic acid
• 化学式: C₁₈H₂₆O₂
• 分子量: 274.4
• InChiKey: LYJOUWBWJDKKEF-RCHUDCCISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  20
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3,6,9,12,15-Octadecapentaenoic acid 、 甲醇 生成 methyl (3E,6E,9E,12E,15E)-octadeca-3,6,9,12,15-pentaenoate
  参考文献：
  名称：

  REZANKA, T., LC AND GC , 8,(1990) N, C. 542, 544-545

  摘要：

  DOI：

文献信息

• REZANKA, T., LC AND GC , 8,(1990) N, C. 542, 544-545
  作者：REZANKA, T.

  DOI：——

  日期：——
• BIODEGRADABLE COMPOSITIONS AND MATERIALS
  申请人：Putnam David Aaron

  公开号：US20100104625A1

  公开（公告）日：2010-04-29

  The present invention provides compounds of Formula I, materials comprising one or more compounds of Formula I and one or more biologically active agents, pharmaceutical compositions comprising an inventive material and a pharmaceutically acceptable excipient, methods of making compounds of Formula I, methods of making inventive materials, and methods of using pharmaceutical compositions comprising an inventive material and a pharmaceutically acceptable excipient.
• DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN
  申请人：Cevc Gregor

  公开号：US20140017301A1

  公开（公告）日：2014-01-16

  The present invention provides drug-free adaptable aggregate compositions, typically having a form of bilayer vesicles suspended in a polar, optionally thickened, fluid comprising different pharmaceutically acceptable excipients for use in or on a mammal for any medical indication, specifically for non-invasive treatment of local inflammation and the associated pain, in particular for use on the skin and underlying tissues, including muscles and/or superficial joints. Accompanying guidelines for selecting components to thereby optimizing the formulations are also provided.
• [EN] BIODEGRADABLE COMPOSITIONS AND MATERIALS<br/>[FR] COMPOSITIONS ET MATÉRIAUX BIODÉGRADABLES
  申请人：UNIV CORNELL

  公开号：WO2008101173A2

  公开（公告）日：2008-08-21

  [EN] The present invention provides compounds of Formula I, materials comprising one or more compounds of Formula I and one or more biologically active agents, pharmaceutical compositions comprising an inventive material and a pharmaceutically acceptable excipient, methods of making compounds of Formula I, methods of making inventive materials, and methods of using pharmaceutical compositions comprising an inventive material and a pharmaceutically acceptable excipient.
  [FR] La présente invention concerne des composés d'une formule I, des matériaux comprenant un ou plusieurs composés de la formule I et un ou plusieurs agents biologiquement actifs, des compositions pharmaceutiques comprenant un matériau novateur et un excipient pharmaceutiquement acceptable, des procédés consistant à fabriquer des composés de la formule I, des procédés consistant à fabriquer des matériaux novateurs, et des procédés consistant à utiliser des compositions pharmaceutiques comprenant un matériau novateur et un excipient pharmaceutiquement acceptable.
• [EN] DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN<br/>[FR] COMPOSITIONS SANS MÉDICAMENT ET MÉTHODES POUR DIMINUER L'INFLAMMATION PÉRIPHÉRIQUE ET LA DOULEUR
  申请人：CEVC GREGOR

  公开号：WO2012126965A1

  公开（公告）日：2012-09-27

  The present invention provides drug-free adaptable aggregate compositions, typically having a form of bilayer vesicles suspended in a polar, optionally thickened, fluid comprising different pharmaceutically acceptable excipients for use in or on a mammal for any medical indication, specifically for non-invasive treatment of local inflammation and the associated pain, in particular for use on the skin and underlying tissues, including muscles and/or superficial joints. Accompanying guidelines for selecting components to thereby optimizing the formulations are also provided.